Acute effect of ephedrine on 24-h energy balance

Clinical Science

Volumn 96, Issue 5, 1999, Pages 483-491

  Shannon, John R ^a   Gottesdiener, Keith ^a   Jordan, Jens ^a   Chen, Kong ^a   Flattery, Stacey ^a   Larson, Patrick J ^a   Candelore, Mari Rios ^a   Gertz, Barry ^a   Robertson, David ^a   Sun, Ming ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

adrenoreceptors; Energy expenditure; Ephedrine; Mechanical work; Noradrenaline

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 3 ADRENERGIC RECEPTOR; CATECHOLAMINE; EPHEDRINE; NORADRENALIN;

ADULT; ARTICLE; CALORIMETRY; CATECHOLAMINE URINE LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; ENERGY BALANCE; ENERGY EXPENDITURE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MANUAL LABOR; NORADRENALIN RELEASE; NORADRENALIN URINE LEVEL; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THERMOGENESIS;

NASA DISCIPLINE REGULATORY PHYSIOLOGY; NON-NASA CENTER;

ADRENERGIC ALPHA-AGONISTS; ADULT; ANALYSIS OF VARIANCE; CALORIMETRY, INDIRECT; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ENERGY METABOLISM; EPHEDRINE; FEMALE; HUMANS; MALE; NOREPINEPHRINE; SYMPATHOMIMETICS;

EID: 0032937329     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS19980206     Document Type: Article

References (45)

1. 1 Heini, A. F. and Weinsier, R. L. (1997) Divergent trends in obesity and fat intake patterns: the American paradox. Am. J. Med. 102, 259-264
2. 2 Peterson, H. R., Rothschild, M, Weinberg, C. R., Fell, R. D., McLeish, K. R. and Pfeifer, M. A. (1988) Body fat and the activity of the autonomic nervous system. N. Engl. J. Med. 318, 1077-1083
3. 3 Saad, M. F., Alger, S. A., Zurlo, F., Young, J. B., Bogardus, C. and Ravussin, E. (1991) Ethnic differences in sympathetic nervous system-mediated energy expenditure. Am. J. Physiol. 261, E789-E794
4. 4 Spraul, M., Ravussin, E., Fontvieille, A. M., Rising, R., Larson, D. E. and Anderson, E. A. (1993) Reduced sympathetic nervous activity. A potential mechanism predisposing to body weight gain. J. Clin. Invest. 92, 1730-1735
5. 5 Widen, E., Lehto, M., Kanninen, T., Walston, J., Shuldiner, A. R. and Groop, L. C. (1995) Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N. Engl. J. Med. 333, 348-351
6. 6 Walston, J., Silver, K., Bogardus, C. et al. (1995) Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene [see comments]. N. Engl. J. Med. 333, 343-347
7. 7 Clement, K., Vaisse, C., Manning, B. S. et al. (1995) Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity [see comments]. N. Engl. J. Med. 333, 352-354
8. 8 Evans, E. and Miller, D. S. (1977) The effect of ephedrine on the oxygen consumption of fed and fasted subjects. Proc. Nutr. Soc. 36, 136A
9. 9 Pasquali, R., Casimirri, F., Melchionda, N. et al. (1992) Effects of chronic administration of ephedrine during very-low-calorie diets on energy expenditure, protein metabolism and hormone levels in obese subjects. Clin. Sci. 82, 85-92
10. 10 Astrup, A., Breum, L., Toubro, S., Hein, P. and Quaade, F. (1992) The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial. Int. J. Obes. Relat. Metab. Disord. 16, 269-277
11. 11 Daly, P. A., Krieger, D. R., Dulloo, A. G., Young, J. B. and Landsberg, L. (1993) Ephedrine, caffeine and aspirin: safety and efficacy for treatment of human obesity. Int. J. Obes. 17 (Suppl. 1), S73-S78
12. 12 Pasquali, R., Baraldi, G., Cesari, M. P. et al. (1985) A controlled trial using ephedrine in the treatment of obesity. Int. J. Obes. 9, 93-98
13. 13 Hoffman, B. B. and Lefkowitz, R. J. (1996) Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In Goodman and Gilman's The Pharmacological Basis of Therapeutics (Hardman, J. G., Limbird, L. E., Molinoff, P. B., Ruddon, R. W. and Gilman, A. G., eds.), pp. 199-248, McGraw-Hill, New York
14. 14 Boobis, A. R., Burley, D., Davies, D. M., Davies, D. S., Harrison, P. I., Orme, M. L., Park, B. K. and Goldberg, L. I. (1991) Ephedrine (hydrochloride). In Therapeutic Drugs (Dollery, C., ed.), pp. E26-E29, Churchill Livingstone, New York
15. 15 Martin, W. R., Sloan, J. W., Sapira, J. D. and Jasinski, D. R. (1971) Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin. Pharmacol. Ther. 12, 245-258
16. 16 Halaas, J. L., Boozer, C., Blair-West, J., Fidhusein, N., Denton, D. A. and Freidman, J. M. (1997) Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc. Natl. Acad. Sci. U.S.A. 94, 8878-8883
17. 17 Levitsky, D. A. and Strupp, B. J. (1985) Direct and indirect thermogenic effects of anorectic drugs [Review]. Adv. Nutr. Res. 7, 187-201
18. 18 FDA. (1996) Docket No. 95N-0304: Food advisory committee meeting: clinical summaries of adverse event reports on dietary supplements that may contain ephedrine alkaloids.
19. 19 Sharp, T. A., Reed, G. W., Sun, M., Abumrad, N. H. and Hill, J. O. (1992) Relationship between aerobic fitness level and daily energy expenditure in weight-stable humans. Am. J. Physiol. 263, E121-E128
20. 20 Sun, M., Reed, G. W. and Hill, J. O. (1994) Modification of a whole room indirect calorimeter for measurement of rapid changes in energy expenditure. J. Appl. Physiol. 76, 2686-2691
21. 21 Sun, M. and Hill, J. O. (1993) A method for measuring mechanical work and work efficiency during human activities. J. Biomech. 26, 229-241
22. 22 Stainsby, W. N., Gladden, L. B., Barclay, J. K. and Wilson, B. A. (1980) Exercise efficiency: validity of base-line subtractions. J. Appl. Physiol. 48, 518-522
23. 23 Flatt, J. P. (1992) The biochemistry of energy expenditure. In Obesity (Bjorntorp, P. and Brodhoff, B. N., eds.), pp. 100-116, J. G. Lippincott, Philadelphia
24. 24 Tataranni, P. A., Larson, D. E., Snitker, S. and Ravussin, E. (1995) Thermic effect of food in humans: methods and results from use of a respiratory chamber. Am. J. Clin. Nutr. 61, 1013-1019
25. 25 Granneman, J. G., Lahners, K. N. and Rao, D. D. (1992) Rodent and human beta 3-adrenergic receptor genes contain an intron within the protein-coding block. Mol. Pharmacol. 42, 964-970
26. 26 Candelore, M. R., Deng, L., Tota, L. M., Kelly, L. J., Cascieri, M. A. and Strader, C. D. (1996) Pharmacological characterization of a recently described human beta 3-adrenergic receptor mutant. Endocrinology (Baltimore) 137, 2638-2641
27. 27 Goldstein, D. S., Eisenhofer, G., Stull, R., Folio, C. J., Keiser, H. R. and Kopin, I. J. (1988) Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans. J. Clin. Invest. 81, 213-220
28. 28 Halaas, J. L., Gajiwala, K. S., Maffei, M. et al. (1995) Weight-reducing effects of the plasma protein encoded by the obese gene. Science (Washington DC) 269, 534-549
29. 29 Blaak, E. E., Sans, W. H. and Baak, M. A. (1997) Adrenoreceptor subtypes mediating catecholamine-induced thermogenesis in man. Int. J. Obes. Relat. Metab. Disord. 17, S78-S81
30. 30 Jansky, L. (1995) Humoral thermogenesis and its role in maintaining energy balance. Physiol. Rev. 75, 237-259
31. 31 Hsieh, A. and Wang, J. C. (1971) Calorigenic responses to cold of rats after prolonged infusion of norepinephrine. Am. J. Physiol. 221, 335-337
32. 32 Jequier, E., Munger, R. and Felber, J. P. (1992) Thermogenic effects of various β-adrenoreceptor agonists in humans: their potential usefulness in the treatment of obesity. Am. J. Clin. Nutr. 55, 249S-251S
33. 33 Blaak, E. E., van, B. A., Kester, A. D. and Saris, W. H. (1995) Beta-adrenergically mediated thermogenic and heart rate responses: effect of obesity and weight loss. Metabolism 44, 520-524
34. 34 Toth, M. J. and Poehlman, E. T. (1994) Sympathetic nervous system activity and resting metabolic rate in vegetarians. Metabolism 43, 621-625
35. 35 Liu, Y. L., Toubro, G., Astrup, A. and Stock, M. J. (1995) Contribution of beta 3-adrenoreceptor activation to ephedrine-induced thermogenesis in humans. Int. J. Obes. Relat. Metab. Disord. 19, 678-685
36. 36 Astrup, A., Toubro, S., Cannon, S., Hein, P. and Madsen, J. (1991) Thermogenic synergism between ephedrine and caffeine in healthy volunteers: a double-blind, placebo-controlled study. Metabolism 40, 323-329
37. 37 Welle, S., Lilavivathana, U. and Campbell, R. G. (1980) Increased plasma norepinephrine concentrations and metabolic rates following glucose ingestion in man. Metabolism 29, 806-809
38. 38 Stromberg, C., Vanakoski, J., Olkkola, K. T., Lindqvist, A., Seppala, T. and Laitinen, L. A. (1992) Exercise alters the pharmacokinetics of midazolam. Clin. Pharmacol. Ther. 51, 527-532
39. 39 Bye, C., Dewsbury, D. and Peck, A. W. (1974) Effects on the human central nervous system of the two isomers of ephedrine and triprolidine, and their interaction. Br. J. Pharmacol. 1, 71-78
40. 40 Bukowiecki, L., Jahjah, L. and Follea, N. (1982) Ephedrine, a potential slimming drug, directly stimulates thermogenesis in brown adipocytes via beta-adrenoreceptors. Int. J. Obes. 6, 343-350
41. 41 Kawasuji, T., Koike, K. and Saito, H. (1996) Effects of optical isomers of ephedrine and methylephedrine on the twitch response in the isolated rat vas deferens and the involvement of alpha 2-adrenoceptors. J. Smooth Muscle Res. 32, 155-163
42. 42 McArdle, W. D., Katch, F. I. and Katch, V. L. (1991) Appendix D. In Exercise Physiology: Energy, Nutrition and Human Performance (McArdle, W. D., Katch, F. I. and Katch, V. L., eds.), pp. 804-811, Lea and Febiger, Philadelphia
43. 43 Breum, L., Pedersen, J. K., Ahlstrom, F. and Frimodt-Moller, J. (1994) Comparison of an ephedrine/caffeine combination and dexfenfluramine in the treatment of obesity. A double-blind multi-centre trial in general practice. Int. J. Obes. Relat. Metab. Disord. 18, 99-103
44. 44 Catlin, D. H. and Hatton, C. K. (1991) Use and abuse of anabolic and other drugs for athletic enhancement. Adv. Int. Med. 36, 399-124
45. 45 Collins, S., Daniel, K. W., Rohlfs, E. M., Ramkumar, V., Taylor, I. L. and Gettys, T. W. (1994) Impaired expression and functional activity of the beta 3-and beta 1-adrenergic receptors in adipose tissue of congenitally obese (C57BL/6J ob/ob) mice. Mol. Endocrinol. 8, 518-527